PRESS RELEASES

Nanospectra Biosciences Announces Enrollment Completion of Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue
November 2, 2021
Nanospectra Biosciences Raises First Tranche of Series B-1 Funding Led by Sirtex Medical
September 8, 2020
Nanospectra Biosciences Announces Four Additional Prestigious Trial Sites for Pivotal AuroLase Study
August 4, 2020

1
2
3
4

MEDIA

NEWS

September 3, 2019
Medscape.com
First Results for Nanosphere Focal Therapy in Prostate Cancer Learn more
September 3, 2019
HoustonChronicle.com
Majority of patients cancer-free after treatment developed at Rice Learn more

1
2
3
4
5
6

BLOG HEADLINE

No items found